AAAAAA

   
Results: 1-8 |
Results: 8
Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9
Authors: Fields, PA Arruda, VR Armstrong, E Chu, K Mingozzi, F Hagstrom, JN Herzog, RW High, KA
Citation: Pa. Fields et al., Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9, MOL THER, 4(3), 2001, pp. 201-210
Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
Authors: Fields, PA Armstrong, E Hagstrom, JN Arruda, VR Murphy, ML Farrell, JP High, KA Herzog, RW
Citation: Pa. Fields et al., Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice, GENE THER, 8(5), 2001, pp. 354-361
Factor V Leiden and intracranial hemorrhage
Authors: Hagstrom, JN
Citation: Jn. Hagstrom, Factor V Leiden and intracranial hemorrhage, BLOOD, 98(9), 2001, pp. 2875-2875
Posttranslational modifications of recombinant myotube-synthesized human factor IX
Authors: Arruda, VR Hagstrom, JN Deitch, J Heiman-Patterson, T Camire, RM Chu, K Fields, PA Herzog, RW Couto, LB Larson, PJ High, KA
Citation: Vr. Arruda et al., Posttranslational modifications of recombinant myotube-synthesized human factor IX, BLOOD, 97(1), 2001, pp. 130-138
Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX
Authors: Fields, PA Kowalczyk, DW Arruda, VR Armstrong, E McCleland, ML Hagstrom, JN Pasi, KJ Ertl, HCJ Herzog, RW High, KA
Citation: Pa. Fields et al., Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX, MOL THER, 1(3), 2000, pp. 225-235
Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter
Authors: Hagstrom, JN Couto, LB Scallan, C Burton, M McCleland, ML Fields, PA Arruda, VR Herzog, RW High, KA
Citation: Jn. Hagstrom et al., Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter, BLOOD, 95(8), 2000, pp. 2536-2542
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
Authors: Herzog, RW Yang, EY Couto, LB Hagstrom, JN Elwell, D Fields, PA Burton, M Bellinger, DA Read, MS Brinkhous, KM Podsakoff, GM Nichols, TC Kurtzman, GJ High, KA
Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63
Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease
Authors: Hagstrom, JN Walter, J Bluebond-Langner, R Amatniek, JC Manno, CS High, KA
Citation: Jn. Hagstrom et al., Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease, J PEDIAT, 133(6), 1998, pp. 777-781
Risultati: 1-8 |